Lexaria Bioscience Corp. (LEXX) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2010: $1.12M2011: $1.68M2012: $1.77M2013: $1.47M2014: $918.0K2015: $55.1K2016: $478.9K2017: $92.3K2018: $43.6K2019: $184.5K2020: $346.0K2021: $203.3K2022: $201.4K2023: $403.9K2024: $1.21M2025: $1.57M$1.57M
2010Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$1.57M+30.1%
2024$1.21M+199.3%
2023$403.9K+100.5%
2022$201.4K-0.9%
2021$203.3K-41.2%
2020$346.0K+87.5%
2019$184.5K+322.8%
2018$43.6K-52.7%
2017$92.3K-80.7%
2016$478.9K+768.7%
2015$55.1K-94.0%
2014$918.0K-37.7%
2013$1.47M-16.7%
2012$1.77M+5.5%
2011$1.68M+49.2%
2010$1.12M